Narrow Straits

Transfecting molecules into cells is as easy as one, two, squeeze.

Written byRuth Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

GEORGE RETSECKA wide array of transfection techniques exist for inserting particular molecules into particular cell types, but what’s needed is a more generalized approach for getting molecules of all shapes and sizes into any type of cell, says Klavs Jensen, professor of chemical engineering at the Massachusetts Institute of Technology. So he devised a method that involves sending cells through narrow microfluidic channels that cause the cells to deform, creating tiny holes in their membranes through which molecules enter by diffusion.

Unlike transfection techniques that require chemical treatments or viral vectors, techniques that rely on physical disruption of cell membranes—such as electroporation, cell shearing, and Jensen’s cell-squeezing approach—have the advantage of being suitable for clinical use. But cell squeezing has an additional benefit, says Mark Prausnitz of the Georgia Institute of Technology, who was not involved in the work.

“The real strength of this approach is that by using a microchannel you have such exquisite control,” Prausnitz says. “You know exactly how big the channel is, you know exactly the velocity of the fluid through it, and you can control [both] perfectly.” Electroporation and cell shearing are coarser by comparison, and thus getting the balance between efficient transfection and minimal cell death is tricky.

Although the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies